Reference
1. Larsen JN, Broge L, Jacobi H. Allergy immunotherapy: the future of
allergy treatment. Drug discovery today. 2016;21(1):26-37.
2. Rapiejko P, Jurkiewicz D, Pietruszewska W, Zielnik-Jurkiewicz B,
Woroń J, Lipiec A. Treatment strategy of allergic rhinitis in the face
of modern world threats. Otolaryngologia polska = The Polish
otolaryngology. 2018;72(2):1-12.
3. Tie K, Miller C, Zanation AM, Ebert CS, Jr. Subcutaneous Versus
Sublingual Immunotherapy for Adults with Allergic Rhinitis: A Systematic
Review with Meta-Analyses. The Laryngoscope. 2021.
4. Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline:
Allergic rhinitis. Otolaryngology–head and neck surgery : official
journal of American Academy of Otolaryngology-Head and Neck Surgery.
2015;152(1 Suppl):S1-43.
5. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic
vaccines for allergic diseases. A WHO position paper. The Journal of
allergy and clinical immunology. 1998;102(4 Pt 1):558-562.
6. Layhadi JA, Eguiluz-Gracia I, Shamji MH. Role of IL-35 in sublingual
allergen immunotherapy. Current opinion in allergy and clinical
immunology. 2019;19(1):12-17.
7. Kiel MA, Röder E, Gerth van Wijk R, Al MJ, Hop WC, Rutten-van Mölken
MP. Real-life compliance and persistence among users of subcutaneous and
sublingual allergen immunotherapy. The Journal of allergy and clinical
immunology. 2013;132(2):353-360.e352.
8. Chhiba KD, Patel GB, Vu THT, et al. Prevalence and characterization
of asthma in hospitalized and nonhospitalized patients with COVID-19.
The Journal of allergy and clinical immunology.
2020;146(2):307-314.e304.
9. Shaker MS, Oppenheimer J, Grayson M, et al. COVID-19: Pandemic
Contingency Planning for the Allergy and Immunology Clinic. The journal
of allergy and clinical immunology In practice.
2020;8(5):1477-1488.e1475.
10. Pfaar O, Demoly P, Gerth van Wijk R, et al. Recommendations for the
standardization of clinical outcomes used in allergen immunotherapy
trials for allergic rhinoconjunctivitis: an EAACI Position Paper.
Allergy. 2014;69(7):854-867.
11. Canonica GW, Baena-Cagnani CE, Bousquet J, et al. Recommendations
for standardization of clinical trials with Allergen Specific
Immunotherapy for respiratory allergy. A statement of a World Allergy
Organization (WAO) taskforce. Allergy. 2007;62(3):317-324.
12. Brożek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its
Impact on Asthma (ARIA) guidelines-2016 revision. The Journal of allergy
and clinical immunology. 2017;140(4):950-958.
13. Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales
can assess the severity of rhinitis graded according to ARIA guidelines.
Allergy. 2007;62(4):367-372.
14. Bousquet PJ, Combescure C, Klossek JM, Daurès JP, Bousquet J. Change
in visual analog scale score in a pragmatic randomized cluster trial of
allergic rhinitis. The Journal of allergy and clinical immunology.
2009;123(6):1349-1354.
15. Poole CD, Bannister CA, Andreasen JN, Andersen JS, Currie CJ.
Estimation of health-related utility (EQ-5D index) in subjects with
seasonal allergic rhinoconjunctivitis to evaluate health gain associated
with sublingual grass allergen immunotherapy. Health and quality of life
outcomes. 2014;12:99.
16. Calderón MA, Casale TB, Demoly P. Validation of Patient-Reported
Outcomes for Clinical Trials in Allergic Rhinitis: A Systematic Review.
The journal of allergy and clinical immunology In practice.
2019;7(5):1450-1461.e1456.
17. Clark J, Schall R. Assessment of combined symptom and medication
scores for rhinoconjunctivitis immunotherapy clinical trials. Allergy.
2007;62(9):1023-1028.
18. Juniper EF, Ståhl E, Doty RL, Simons FE, Allen DB, Howarth PH.
Clinical outcomes and adverse effect monitoring in allergic rhinitis.
The Journal of allergy and clinical immunology. 2005;115(3 Suppl
1):S390-413.
19. Juniper EF, Guyatt GH. Development and testing of a new measure of
health status for clinical trials in rhinoconjunctivitis. Clinical and
experimental allergy : journal of the British Society for Allergy and
Clinical Immunology. 1991;21(1):77-83.
20. Kang Y, Liu S, Yang L, et al. Testing the Bidirectional Associations
of Mobile Phone Addiction Behaviors With Mental Distress, Sleep
Disturbances, and Sleep Patterns: A One-Year Prospective Study Among
Chinese College Students. Frontiers in psychiatry. 2020;11:634.
21. Yuan L, Pan B, Wang W, Wang L, Zhang X, Gao Y. Prevalence and
predictors of anxiety and depressive symptoms among patients diagnosed
with oral cancer in China: a cross-sectional study. BMC psychiatry.
2020;20(1):394.
22. Liu P, Zeng F, Zhou G, et al. Alterations of the default mode
network in functional dyspepsia patients: a resting-state fmri study.
Neurogastroenterology and motility : the official journal of the
European Gastrointestinal Motility Society. 2013;25(6):e382-388.
23. Peng M, Mo B, Liu Y, et al. Prevalence, risk factors and clinical
correlates of depression in quarantined population during the COVID-19
outbreak. Journal of affective disorders. 2020;275:119-124.
24. Wu K, Wei X. Analysis of Psychological and Sleep Status and Exercise
Rehabilitation of Front-Line Clinical Staff in the Fight Against
COVID-19 in China. Medical science monitor basic research.
2020;26:e924085.
25. Cai X, Hu X, Ekumi IO, et al. Psychological Distress and Its
Correlates Among COVID-19 Survivors During Early Convalescence Across
Age Groups. The American journal of geriatric psychiatry : official
journal of the American Association for Geriatric Psychiatry.
2020;28(10):1030-1039.
26. Zhang T, Yu GD, Gu P, Tang Q, Jin Y, He XC. [Evaluation and
analysis of anxiety, depression and quality of life in vasomotor
rhinitis]. Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese
journal of otorhinolaryngology head and neck surgery.
2020;55(8):769-773.
27. Liu S, Wu R, Li L, et al. The prevalence of anxiety and depression
in Chinese asthma patients. PloS one. 2014;9(7):e103014.
28. Hao T, Youxiang M, Xiuyong D, Ruxiang Z, Jiao X. [Prevalence and
psychopathological characteristics of anxiety and depression in patients
with chronic rhinosinusitis before endoscopic sinus surgery]. Zhonghua
er bi yan hou tou jing wai ke za zhi = Chinese journal of
otorhinolaryngology head and neck surgery. 2015;50(3):210-214.
29. Li Y, Zhang H, Wang Y. Tai Chi Ameliorates Coronary Heart Disease by
Affecting Serum Levels of miR-24 and miR-155. Frontiers in physiology.
2019;10:587.
30. Wang T, Li S, Jiang G, et al. Regional homogeneity changes in
patients with primary insomnia. European radiology.
2016;26(5):1292-1300.
31. Guo Z, Tang HY, Li H, et al. The benefits of psychosocial
interventions for cancer patients undergoing radiotherapy. Health and
quality of life outcomes. 2013;11:121.
32. Pfaar O, Agache I, Bonini M, et al. COVID-19 pandemic and allergen
immunotherapy - an EAACI survey. Allergy. 2021;10(2):111.
33. Klimek L, Jutel M, Akdis C, et al. Handling of allergen
immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement.
Allergy. 2020;75(7):1546-1554.
34. WH. O. Infection prevention and control of epidemic-and pandemic
prone acute respiratory infections in health care.
35. ECfDPa. C. Guidance for wearing and removing personal protective
equipment in healthcare settings for the care of patients with suspected
or confirmed COVID-19.
36. Lei L, Huang X, Zhang S, Yang J, Yang L, Xu M. Comparison of
Prevalence and Associated Factors of Anxiety and Depression Among People
Affected by versus People Unaffected by Quarantine During the COVID-19
Epidemic in Southwestern China. Medical science monitor : international
medical journal of experimental and clinical research. 2020;26:e924609.
37. Pfaar O, Klimek L, Jutel M, et al. COVID-19 pandemic: Practical
considerations on the organization of an allergy clinic - an EAACI/ARIA
Position Paper. Allergy. 2020.
38. Imai R, Hori H, Itoh M, et al. Inflammatory markers and their
possible effects on cognitive function in women with posttraumatic
stress disorder. Journal of psychiatric research. 2018;102:192-200.
39. Portnoy J, Waller M, Elliott T. Telemedicine in the Era of COVID-19.
The journal of allergy and clinical immunology In practice.
2020;8(5):1489-1491.
40. Waibel KH, Bickel RA, Brown T. Outcomes From a Regional Synchronous
Tele-Allergy Service. The journal of allergy and clinical immunology In
practice. 2019;7(3):1017-1021.
41. Shaker MS, Mosnaim G, Oppenheimer J, Stukus D, Abrams EM, Greenhawt
M. Health and Economic Outcomes of Home Maintenance Allergen
Immunotherapy in Select Patients with High Health Literacy during the
COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional
Times. The journal of allergy and clinical immunology In practice.
2020;8(7):2310-2321.e2314.
42. Malipiero G, Paoletti G, Puggioni F, et al. An academic allergy unit
during COVID-19 pandemic in Italy. The Journal of allergy and clinical
immunology. 2020;146(1):227.
43. Malipiero G, Heffler E, Pelaia C, et al. Allergy clinics in times of
the SARS-CoV-2 pandemic: an integrated model. Clinical and translational
allergy. 2020;10:23.
44. Codispoti CD, Bandi S, Moy JN, Mahdavinia M. Running a virtual
allergy division and training program in the time of COVID-19 pandemic.
The Journal of allergy and clinical immunology. 2020;145(5):1357-1359.
45. Matricardi PM, Dramburg S, Alvarez-Perea A, et al. The role of
mobile health technologies in allergy care: An EAACI position paper.
Allergy. 2020;75(2):259-272.
46. Abi Fadel F, Al-Jaghbeer M, Kumar S, et al. The impact of the state
of Ohio stay-at-home order on non-COVID-19 intensive care unit
admissions and outcomes. Anaesthesiology intensive therapy.
2020;52(3):249-252.
47. Klimek L, Pfaar O, Worm M, et al. Allergen immunotherapy in the
current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI
and GPA: Position paper of the German ARIA Group(A) in cooperation with
the Austrian ARIA Group(B), the Swiss ARIA Group(C), German Society for
Applied Allergology (AEDA)(D), German Society for Allergology and
Clinical Immunology (DGAKI)(E), Society for Pediatric Allergology
(GPA)(F) in cooperation with AG Clinical Immunology, Allergology and
Environmental Medicine of the DGHNO-KHC(G) and the European Academy of
Allergy and Clinical Immunology (EAACI)(H). Allergologie select.
2020;4:44-52.
48. Torlinski T. Initial hospital preparation and response to fight the
COVID-19 pandemic, based on the British university hospital experience.
Anaesthesiology intensive therapy. 2020;52(3):256-258.
49. Zieliński M, Wróblewski P, Kozielski J. Proposed practice guidelines
for burn centres in the context of the SARS-CoV-2 pandemic.
Anaesthesiology intensive therapy. 2020;52(3):245-248.
50. Jutel M, Brüggenjürgen B, Richter H, Vogelberg C. Real-world
evidence of subcutaneous allergoid immunotherapy in house dust
mite-induced allergic rhinitis and asthma. Allergy.
2020;75(8):2050-2058.